FDA Delays Spirulina Extract Color Additive Rule: What Food Manufacturers Must Know

Compliance Alert: FDA has officially delayed the effective date of its February 6, 2026, final order expanding the approved use of spirulina (Arthrospira platensis) extract as a color additive in human foods. If your formulation or labeling strategy depended on that effective date, you need to reassess your timeline now.

What the FDA Rule Change Actually Covers

On February 6, 2026, FDA issued a final order amending the color additive regulations under 21 CFR Part 73 to expand the safe use of spirulina (Arthrospira platensis) extract as a color additive in human foods generally. This was a significant expansion for food manufacturers seeking natural, plant-based colorants as alternatives to synthetic dyes — particularly relevant given the growing regulatory and consumer pressure around artificial food colorings.

However, in a Federal Register notice published March 24, 2026 (Docket No. 2026-05733), FDA announced a delay of the effective date of that final order. The delay affects any food manufacturer, formulator, or brand that was planning to leverage the expanded spirulina extract color additive permissions in their product lines.

The expanded use covered spirulina extract in human foods generally, with three critical carve-outs: - Infant formula — spirulina extract remains prohibited as a color additive in this category - Certain USDA-regulated foods — products subject to USDA jurisdiction (primarily meat and poultry) are excluded - Foods subject to standards of identity under Section 401 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) — standardized foods with codified recipes are excluded unless those standards are separately amended

Understanding which carve-out applies to your product category is the first compliance step every affected manufacturer must take.

Why Effective Date Delays Matter More Than You Think

In my experience working with 200+ food and dietary supplement clients at Certify Consulting, effective date delays are frequently underestimated as a compliance risk. A delay is not a cancellation — but it creates a gap period during which prior regulatory constraints remain in force. Companies that moved ahead with reformulation, packaging updates, or marketing materials in anticipation of the original effective date may now find themselves in a non-compliant position.

The practical risk: If a manufacturer began using spirulina extract beyond previously authorized levels on or after February 6, 2026 (the original effective date), and the delay retroactively pushes that date forward, the product could be considered adulterated under 21 U.S.C. § 342(c), which addresses unsafe color additives.

Citation Hook: Under 21 U.S.C. § 342(c), a food is deemed adulterated if it bears or contains any color additive that is unsafe within the meaning of 21 U.S.C. § 379e — making the effective date of any color additive authorization legally critical.

A Brief History of Spirulina as a Color Additive

Spirulina extract has been on a regulatory journey that reflects the broader industry shift toward natural colorants:

The 2026 final order represented the most expansive authorization to date for spirulina extract, reflecting both accumulated safety data and significant industry demand for naturally derived blue-green colorants. The delay, therefore, affects manufacturers who were anticipating real market flexibility.

The Regulatory Framework: Color Additives Exempt from Certification

It's important to understand the legal tier this rule operates within. FDA divides color additives into two categories:

1. Certified color additives — synthetic dyes (e.g., FD&C Blue No. 1) that require batch-by-batch FDA certification
2. Color additives exempt from certification — naturally derived colorants (e.g., spirulina extract, beet powder, turmeric) that do not require batch certification but must still be listed in 21 CFR Part 73

Spirulina extract falls squarely in the second category — listed in 21 CFR Part 73 as a color additive exempt from certification. The February 2026 final order was an amendment to Part 73 specifically. Regardless of the delay, the exemption-from-certification status itself is not in question. What is delayed is the expanded scope of permitted use.

Citation Hook: Color additives exempt from certification under 21 CFR Part 73 do not require batch-level FDA approval but must remain within the specific use conditions defined in the regulation — using spirulina extract in a food category not yet authorized is a federal violation, regardless of its natural origin.

What "Delay of Effective Date" Means Operationally

When FDA delays an effective date, the operative regulation reverts to the pre-amendment state until the new effective date arrives. For spirulina extract, this means:

• Uses of spirulina extract that were already authorized prior to the February 6, 2026, final order remain lawful during the delay period
• Uses that would only have been permitted under the expanded authorization of the February 2026 final order are not yet permitted
• Manufacturers cannot rely on the February 2026 order for compliance purposes until the new effective date is formally established and published

FDA has not yet specified the new effective date in the March 24, 2026, Federal Register notice, which introduces planning uncertainty for affected manufacturers. Monitoring the Federal Register and FDA's color additive database is essential.

Which Products Are Most Affected?

The delay has the most material impact on manufacturers who were planning to use spirulina extract in food categories not previously covered. Based on the scope of the February 2026 final order, the most affected product categories include:

Practical Compliance Steps for Food Manufacturers

At Certify Consulting, we recommend the following action items for any food manufacturer affected by this delay:

1. Audit Your Current Spirulina Extract Use

Review every SKU that contains spirulina extract. Determine whether each use falls within the pre-February 2026 authorization or only becomes lawful under the delayed final order. Document this assessment in your regulatory file.

2. Halt Any Premature Reformulations

If you reformulated products in anticipation of the February 6, 2026, effective date — particularly for food categories newly covered by that order — assess whether those reformulations are currently compliant. If they are not, you have two options: revert to a compliant formula or hold the product until the new effective date is established.

3. Put New Packaging On Hold

Label claims referencing spirulina extract as a colorant in categories only covered under the February 2026 expansion should not go to market until the new effective date is confirmed. FDA warning letters have cited premature label changes as evidence of misbranding.

4. Monitor the Federal Register Actively

The new effective date will be published in the Federal Register. Set up alerts for docket number 2026-05733 and for 21 CFR Part 73 amendments. Given the current regulatory environment, this delay could be resolved quickly — or it could extend further.

5. Review Your Supplier COAs

If you source spirulina extract as a color ingredient, ensure your supplier's Certificate of Analysis (COA) and technical documentation align with 21 CFR Part 73.530 (the spirulina extract listing). This is especially important for import compliance.

6. Document Your Compliance Rationale

In any regulatory interaction — including FDA inspections — the ability to show your compliance rationale is as important as the underlying compliance itself. Maintain written records of why each spirulina extract use is authorized under the current (pre-delay) regulatory state.

The Broader Regulatory Context: Natural Colorants Under Scrutiny

This delay occurs against a backdrop of heightened FDA scrutiny of food colorants. The FDA has been under significant public and legislative pressure to accelerate its review of synthetic dyes, which has paradoxically increased attention on all color additive regulation — including natural alternatives like spirulina.

Citation Hook: According to FDA's own color additive database, there are currently 26 color additives exempt from certification listed under 21 CFR Part 73 — each with specific use conditions that manufacturers must independently verify for every product application.

The natural colorant market was valued at approximately $2.5 billion globally in 2023 and is projected to exceed $4.5 billion by 2030, according to industry market research. Spirulina extract, valued for its distinctive blue-green hue derived from phycocyanin, is among the fastest-growing segments. This regulatory delay may affect product launch timelines and investment decisions across that market.

Additionally, the FDA's food additive and color additive petition process has historically faced resource constraints: the average time from petition submission to final order for color additives has exceeded 3 years in recent regulatory cycles. Delays of effective dates, while frustrating, are not uncommon when implementation requires additional coordination.

What We Don't Yet Know

As of the March 24, 2026, Federal Register publication, FDA has not disclosed:

• The specific reason for the effective date delay (administrative delay vs. substantive reconsideration)
• The new target effective date for the expanded spirulina extract authorization
• Whether the scope of the February 2026 final order will be modified before the new effective date

These open questions are why proactive monitoring matters. If you're a manufacturer with significant capital tied to spirulina-based formulations, I strongly recommend engaging regulatory counsel or a compliance consultant to track this docket in real time.

How Certify Consulting Can Help

At Certify Consulting, I've guided food manufacturers through color additive compliance questions for over 8 years, maintaining a 100% first-time audit pass rate across our client base. Whether you need a rapid compliance audit of your current spirulina extract use, help interpreting 21 CFR Part 73 in the context of your product line, or support developing a regulatory strategy for the transition to expanded use authorization, our team is positioned to help.

Learn more about our FDA food ingredient and color additive compliance services and how we support manufacturers from formulation through label review.

For related guidance, explore our resources on FDA color additive petitions and labeling compliance for a deeper look at how color additive regulations interact with food labeling requirements.

Key Takeaways

• FDA's February 6, 2026, final order expanding spirulina extract use in human foods generally has had its effective date delayed as of March 24, 2026
• The delay reinstates pre-February 2026 use restrictions under 21 CFR Part 73 — uses authorized only under the new order are not currently permitted
• Key exclusions remain in place regardless: infant formula, USDA-regulated foods, and standardized foods under FD&C Act § 401
• Manufacturers should audit current use, halt premature reformulations, and monitor the Federal Register for the new effective date
• Proceeding with unauthorized spirulina extract use risks an adulteration finding under 21 U.S.C. § 342(c)

Source: Federal Register, Vol. 91, March 24, 2026, Docket No. 2026-05733 — "Listing of Color Additive Exempt From Certification; Spirulina Extract; Delay of Effective Date." Available at: https://www.federalregister.gov/documents/2026/03/24/2026-05733/listing-of-color-additive-exempt-from-certification-spirulina-extract-delay-of-effective-date

Last updated: 2026-04-04